Cargando…
Activated phosphoinositide 3-kinase delta syndrome 2 associated with Kikuchi–Fujimoto disease: a rare Palestinian case report
Histiocytic necrotic lymphadenitis (HNL), also known as Kikuchi–Fujimoto disease (KFD), is a rare local lymphadenopathy with a benign course and clinical manifestations such as fever, lymphadenopathy, rash, hepatosplenomegaly, central nervous system (CNS) symptoms, and hemophilic cell syndrome. It w...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205224/ https://www.ncbi.nlm.nih.gov/pubmed/37229047 http://dx.doi.org/10.1097/MS9.0000000000000476 |
_version_ | 1785045990158368768 |
---|---|
author | Abulaila, Karim J. Sabha, Mosa A. Misk, Momin R. Alhalabeye, Amr A. Jobran, Afnan W.M. Abunejma, Fawzy M. Bakri, Izzeddin A. |
author_facet | Abulaila, Karim J. Sabha, Mosa A. Misk, Momin R. Alhalabeye, Amr A. Jobran, Afnan W.M. Abunejma, Fawzy M. Bakri, Izzeddin A. |
author_sort | Abulaila, Karim J. |
collection | PubMed |
description | Histiocytic necrotic lymphadenitis (HNL), also known as Kikuchi–Fujimoto disease (KFD), is a rare local lymphadenopathy with a benign course and clinical manifestations such as fever, lymphadenopathy, rash, hepatosplenomegaly, central nervous system (CNS) symptoms, and hemophilic cell syndrome. It was first identified by Japanese pathologists Kikuchi and Fujimoto. KFD damages the meninges, the brain parenchyma, and peripheral nerves in addition to the CNS. Neurological symptoms may even be the most obvious clinical manifestations or initial symptoms of the disease. CASE PRESENTATION: We present a unique case of a 7-year-old male patient who was diagnosed with activated phosphoinositide 3-kinase delta syndrome 2 (APDS 2) associated with KFD, a HNL during a workup for fever without a focus and cervical lymphadenopathy. CONCLUSION: Highlighted the unique relationship between two uncommon conditions and stressed the significance of adding KFD to the list of possible diagnoses for lymphadenopathy in APDS 2. Furthermore, we demonstrate that patients with APDS 2 may exhibit low immunoglobulin M levels. |
format | Online Article Text |
id | pubmed-10205224 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-102052242023-05-24 Activated phosphoinositide 3-kinase delta syndrome 2 associated with Kikuchi–Fujimoto disease: a rare Palestinian case report Abulaila, Karim J. Sabha, Mosa A. Misk, Momin R. Alhalabeye, Amr A. Jobran, Afnan W.M. Abunejma, Fawzy M. Bakri, Izzeddin A. Ann Med Surg (Lond) Case Reports Histiocytic necrotic lymphadenitis (HNL), also known as Kikuchi–Fujimoto disease (KFD), is a rare local lymphadenopathy with a benign course and clinical manifestations such as fever, lymphadenopathy, rash, hepatosplenomegaly, central nervous system (CNS) symptoms, and hemophilic cell syndrome. It was first identified by Japanese pathologists Kikuchi and Fujimoto. KFD damages the meninges, the brain parenchyma, and peripheral nerves in addition to the CNS. Neurological symptoms may even be the most obvious clinical manifestations or initial symptoms of the disease. CASE PRESENTATION: We present a unique case of a 7-year-old male patient who was diagnosed with activated phosphoinositide 3-kinase delta syndrome 2 (APDS 2) associated with KFD, a HNL during a workup for fever without a focus and cervical lymphadenopathy. CONCLUSION: Highlighted the unique relationship between two uncommon conditions and stressed the significance of adding KFD to the list of possible diagnoses for lymphadenopathy in APDS 2. Furthermore, we demonstrate that patients with APDS 2 may exhibit low immunoglobulin M levels. Lippincott Williams & Wilkins 2023-04-07 /pmc/articles/PMC10205224/ /pubmed/37229047 http://dx.doi.org/10.1097/MS9.0000000000000476 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (https://creativecommons.org/licenses/by-nc/4.0/) (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) |
spellingShingle | Case Reports Abulaila, Karim J. Sabha, Mosa A. Misk, Momin R. Alhalabeye, Amr A. Jobran, Afnan W.M. Abunejma, Fawzy M. Bakri, Izzeddin A. Activated phosphoinositide 3-kinase delta syndrome 2 associated with Kikuchi–Fujimoto disease: a rare Palestinian case report |
title | Activated phosphoinositide 3-kinase delta syndrome 2 associated with Kikuchi–Fujimoto disease: a rare Palestinian case report |
title_full | Activated phosphoinositide 3-kinase delta syndrome 2 associated with Kikuchi–Fujimoto disease: a rare Palestinian case report |
title_fullStr | Activated phosphoinositide 3-kinase delta syndrome 2 associated with Kikuchi–Fujimoto disease: a rare Palestinian case report |
title_full_unstemmed | Activated phosphoinositide 3-kinase delta syndrome 2 associated with Kikuchi–Fujimoto disease: a rare Palestinian case report |
title_short | Activated phosphoinositide 3-kinase delta syndrome 2 associated with Kikuchi–Fujimoto disease: a rare Palestinian case report |
title_sort | activated phosphoinositide 3-kinase delta syndrome 2 associated with kikuchi–fujimoto disease: a rare palestinian case report |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205224/ https://www.ncbi.nlm.nih.gov/pubmed/37229047 http://dx.doi.org/10.1097/MS9.0000000000000476 |
work_keys_str_mv | AT abulailakarimj activatedphosphoinositide3kinasedeltasyndrome2associatedwithkikuchifujimotodiseaseararepalestiniancasereport AT sabhamosaa activatedphosphoinositide3kinasedeltasyndrome2associatedwithkikuchifujimotodiseaseararepalestiniancasereport AT miskmominr activatedphosphoinositide3kinasedeltasyndrome2associatedwithkikuchifujimotodiseaseararepalestiniancasereport AT alhalabeyeamra activatedphosphoinositide3kinasedeltasyndrome2associatedwithkikuchifujimotodiseaseararepalestiniancasereport AT jobranafnanwm activatedphosphoinositide3kinasedeltasyndrome2associatedwithkikuchifujimotodiseaseararepalestiniancasereport AT abunejmafawzym activatedphosphoinositide3kinasedeltasyndrome2associatedwithkikuchifujimotodiseaseararepalestiniancasereport AT bakriizzeddina activatedphosphoinositide3kinasedeltasyndrome2associatedwithkikuchifujimotodiseaseararepalestiniancasereport |